Clinical Trial Update: A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating different doses of 0382 in overweight and obese adults with Type 2 Diabetes Mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• 0382

Snippet

Sponsor: MedImmune LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-11-19